Cencora Inc. (COR)
$268.13+0.16%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Drug-distribution oligopoly with unbroken 20-year dividend growth; specialty pivot builds earnings but acquisition debt is elevated.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment…
- Sector:
- Healthcare
- Industry:
- Medical Distribution
- Market Cap:
- $50.8B
Recent dividends
- 15 May 2026$0.60
- 13 Feb 2026$0.60
- 14 Nov 2025$0.60
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Cencora Inc. and 1,600+ UK and US stocks.
Start free